oral Toll-like receptor TLR7 agonist

3 mg Q2W, Ph. II for HIV/AIDS

from opt. of 8-oxopurine agonist

Science Translational Medicine

Gilead Sciences, Foster City, CA

vesatolimod

8. The Gilead Toll-like receptor 7 (TLR7) agonist, vesatolimod (GS-9620), is a tolerated, low-dose oral TLR7 agonist. It is intended to induce immune cell activation to help eliminate reservoirs…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: